Axogen Reports Third-Quarter 2026 Financial Results

Raises Full Year Revenue Guidance to at Least 29% Growth or $290 millionALACHUA and TAMPA, Fla., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. NASDAQ:AXGN, a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported fin…